NCT05471609View on ClinicalTrials.gov

Sustained Release Oral Formulation for Treatment of Parkinson's Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 12, 2025

Primary Completion Date

June 16, 2026

Study Completion Date

June 16, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

levodopa/carbidopa oral formulation A

Outer sachet 100mg CD/100mg LD and inner sachet 0mg CD /300mg LD

DRUG

levodopa/carbidopa oral formulation B

Outer sachet 100mg CD/0mg LD and inner sachet 0mg CD /400mg LD

Trial Locations (1)

55455

RECRUITING

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER